OTCMCBSTF
Market cap32mUSD
Jan 10, Last price
0.07USD
1D
-8.14%
1Q
-65.53%
IPO
-92.58%
Name
Columbia Care Inc
Chart & Performance
P/E
—
P/S
0.07
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
13.91%
Rev. gr., 5y
330.01%
Revenues
511m
+4.07%
Net income
-176m
L-56.02%
CFO
7m
P
Earnings
Mar 11, 2025
Profile
Columbia Care Inc. cultivates, manufactures, and provides cannabis products and related services. It offers flowers, edibles, oils, and tablets under the Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber, and Platinum Label CBD brands. The company holds licenses in 18 jurisdictions in the United States and the European Union. As of June 15, 2022, it operated 131 facilities, including 99 dispensaries and 32 cultivation and manufacturing facilities. The company was founded in 2012 and is headquartered in New York, New York.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||
Revenues | 511,327 4.07% | 491,308 7.74% | ||||
Cost of revenue | 495,592 | 573,042 | ||||
Unusual Expense (Income) | ||||||
NOPBT | 15,735 | (81,734) | ||||
NOPBT Margin | 3.08% | |||||
Operating Taxes | 5,389 | (10,769) | ||||
Tax Rate | 34.25% | |||||
NOPAT | 10,346 | (70,965) | ||||
Net income | (175,712) -56.02% | (399,522) 181.67% | ||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 25,000 | (57) | ||||
BB yield | ||||||
| Debt | ||||||
Debt current | 22,955 | 60,602 | ||||
Long-term debt | 766,310 | 506,373 | ||||
Deferred revenue | 224,796 | |||||
Other long-term liabilities | 74,346 | 75,165 | ||||
Net debt | 752,726 | 511,814 | ||||
| Cash flow | ||||||
Cash from operating activities | 7,471 | (106,987) | ||||
CAPEX | (9,966) | (72,714) | ||||
Cash from investing activities | (3,499) | (72,342) | ||||
Cash from financing activities | (14,383) | 147,595 | ||||
FCF | 57,439 | (112,187) | ||||
| Balance | ||||||
Cash | 35,764 | 48,132 | ||||
Long term investments | 775 | 7,029 | ||||
Excess cash | 10,973 | 30,596 | ||||
Stockholders' equity | (1,080,794) | (909,971) | ||||
Invested Capital | 1,766,816 | 1,724,975 | ||||
ROIC | 0.59% | |||||
ROCE | 2.29% | |||||
| EV | ||||||
Common stock shares outstanding | 402,777 | 392,571 | ||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | 78,464 | (307) | ||||
EV/EBITDA | ||||||
Interest | 54,865 | 53,897 | ||||
Interest/NOPBT | 348.68% | |||||